CSL - Net Income


CSL reported $401M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Arca Biopharma USD -31.82M 2.24M Mar/2026
aTyr Pharma USD -153K 24.71M Mar/2026
Bio Path USD -270K 706K Mar/2026
Brainstorm Cell Therapeutics USD -2.13M 21K Mar/2026
Cara Therapeutics USD -6.8M 1.28M Mar/2026
CSL USD 401M 96.5M Dec/2025
Curis USD -24.2M 43.56M Mar/2026
Immunic USD -19.3M 6.28M Dec/2025
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
TherapeuticsMD USD -1.09M 356K Jun/2024